The boundary between science fiction and medical reality blurs as companies like Elon Musk's Neuralink make strides in ...
The new director at the FDA overseeing medical devices will confront criticisms about hasty approvals as she ushers in ...
Michael Mager of Precision Neuroscience, a brain implant startup rival to Elon Musk's Neuralink, sounds off on the future of ...
Neuralink has claimed in a tweet that it has finally received approval from the FDA to start a first-in-human clinical trial of its brain implant chip – but hasn’t indicated when it may start.
Michelle Tarver, MD, PhD, a 15-year veteran of the agency, is stepping into a pivotal role as the new director of the FDA's device division, taking over for Jeffrey Shuren, MD. Dr. Shuren's tenure was ...
Robert F. Kennedy Jr. suggested the second Trump administration could eliminate entire departments within the Food and Drug Administration (FDA) for "corruption." The former independent ...
The Food and Drug Administration (FDA) said it will reconsider its decision to remove Eli Lilly’s blockbuster weight loss and diabetes drug from its official shortage list and allow compounding ...
Elon Musk’s substantial support for Donald Trump’s re-election has the potential to reshape regulatory oversight across his ...
Oct. 16, 2024 — Before the FDA allows prescription medicines on the market, drugmakers must prove they’re safe and effective. What’s less widely known is that most medical devices ...
FDA Says Compounding Pharmacies Can Keep Making Weight-Loss Med Tirzepatide, for Now By Robin Foster HealthDay Reporter TUESDAY, Oct. 15, 2024 (HealthDay News) -- Pharmacists may continue making ...
Tirzepatide was first approved by the Food and Drug Administration (FDA) in 2022 and has no generic versions on the market. But when the drug was declared to be in shortage in December that same ...
The FDA has agreed to review its decision to remove Eli Lilly’s LLY tirzepatide — the active ingredient used in diabetes drug Mounjaro and obesity drug Zepbound — from its shortage list.